This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ascendis Pharma Bone Diseases A/s. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Duelund Sørensen: Innovator in Pharmaceutical Formulations
Introduction
Michael Duelund Sørensen is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations.
Latest Patents
One of his key patents is titled "Liquid pharmaceutical formulations of PTH conjugates." This patent describes a liquid pharmaceutical formulation that includes a PTH conjugate, a buffering agent, an isotonicity agent, a preservative, and optionally an antioxidant. The PTH conjugate consists of a PTH moiety that is covalently and reversibly conjugated to a water-soluble carrier moiety. This formulation aims to enhance the delivery and efficacy of pharmaceutical treatments.
Career Highlights
Michael currently works at Ascendis Pharma Bone Diseases A/S, where he continues to innovate in the pharmaceutical sector. His work focuses on developing advanced treatments for bone diseases, leveraging his expertise in pharmaceutical formulations.
Collaborations
He collaborates with talented professionals in his field, including Anja R H Skands and Felix Cleemann. Their combined efforts contribute to the advancement of pharmaceutical research and development.
Conclusion
Michael Duelund Sørensen is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions and dedication to improving healthcare solutions. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile